International Society of Pharmacovigilance Special Interest Group

Bayer
Bayer co-founded an International Society of Pharmacovigilance Special Interest Group to develop and share innovative risk minimisation methods and tools.
Continue reading
Leprosy-focused Capacity Building

Leprosy-focused capacity building

Novartis
Novartis is undertaking a range of projects to build local capacity to address leprosy, mainly in south-east Asia.
Continue reading
Informed Push Model

Informed Push Model

Merck & Co
The Informed Push Model is a distribution project aiming to improve supply chains and stock management for contraceptives in Senegal.
Continue reading
SMS For Life

SMS for Life

Novartis
Novartis’ SMS for Life programme uses mobile technology to reduce medicine stock-outs in sub-Saharan Africa.
Continue reading

Approach to R&D capacity building

Novartis
Novartis takes a comprehensive approach to targeting local R&D capacity building needs.
Continue reading
Tianjin University-AstraZeneca Joint Laboratory

Tianjin University-AstraZeneca Joint Laboratory

AstraZeneca
AstraZeneca partners with Tianjin University to improve manufacturing safety standards in China.
Continue reading

Manufacturing capacity building approach

Merck KGaA
Merck KGaA takes a comprehensive approach to building manufacturing capacity in-house and with third parties.
Continue reading

M-Tiba mobile wallet

Pfizer
Pfizer has supported the development and implementation of M-Tiba, a mobile wallet for healthcare savings and payments.
Continue reading

Global Health Pharma Fund Minilab

Merck KGaA
Merck KGaA supports the Global Pharma Health Fund (GPHF) Minilab, a mobile medicine authenticator.
Continue reading

Malaria-focused capacity building

Novartis
Novartis is undertaking several capacity building projects focused on malaria in sub-Saharan Africa.
Continue reading
Healthy Heart Africa Capacity Building Activities

Healthy Heart Africa capacity building activities

AstraZeneca
AstraZeneca’s Healthy Heart Africa programme includes a range of capacity building activities to help reduce the burden of hypertension in Kenya.
Continue reading
R&D Capacity Building Model

R&D capacity building model

GSK
GSK has a comprehensive model to build local R&D capacity in response to need.
Continue reading

Tuberculosis-focused capacity building

Eli Lilly
Eli Lilly is undertaking a range of capacity building projects in India focused on tuberculosis.
Continue reading
Young Health Programme

Young Health Programme

AstraZeneca
AstraZeneca’s Young Health Programme is a philanthropic capacity building programme focused on preventing non-communicable diseases among adolescents.
Continue reading

African Association of Essential Drugs National Purchasing Centres training partnership

Sanofi
Sanofi has a training partnership with the African Association of Essential Drugs National Purchasing Centres (ACAME).
Continue reading

StartHealth investment programme

Pfizer
Pfizer is supporting StartHealth, a health technology start-up investment programme.
Continue reading
Africa 2020 R&D Capacity Building

Africa 2020 R&D capacity building

GSK
GSK’s Africa 2020 strategy includes a range of R&D capacity building partnerships in sub-Saharan Africa.
Continue reading
Developing Country Vaccine Manufacturers Network Training Partnership

Developing Country Vaccine Manufacturers Network training partnership

Merck KGaA
Merck KGaA has a training partnership with the Developing Countries Vaccine Manufacturers Network (DCVMN).
Continue reading
MVacciNation

mVacciNation

GSK
GSK’s mVacciNation programme is a mobile technology-based supply chain management capacity building programme, aiming to increase childhood immunisation in Mozambique.
Continue reading

Possible partnership

Merck & Co
Merck & Co., Inc. partnered with non-government organisation (NGO) Possible to strengthen supply chains in Nepal.
Continue reading